All Updates

All Updates

icon
Filter
Funding
Partnerships
Kryptos Biotechnologies raises USD 10 million in Series A funding to advance clinical studies and regulatory approval for molecular diagnostics system
Precision Medicine
Apr 4, 2024
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Precision Medicine

Precision Medicine

Apr 4, 2024

Kryptos Biotechnologies raises USD 10 million in Series A funding to advance clinical studies and regulatory approval for molecular diagnostics system

Funding
Partnerships

  • Kryptos Biotechnologies has raised USD 10 million in a Series A funding round led by South Korea's Osang Healthcare.

  • The funding will be used to advance clinical studies of respiratory combo tests, which target FDA approval by 2025. The funds will also be used to further develop Kuick, Kryptos’ molecular diagnostic system for rapid, accurate, and affordable point-of-care testing.

  • In addition to the funding, the company has also formed a strategic alliance with Osang Healthcare to manufacture and distribute its product. Kryptos leverages its novel photothermal heating technology to enhance molecular diagnostic devices and various life sciences instruments. The company has developed a point-of-care molecular diagnostics system named "Kuick, which reduces the time for test results by approximately 20 minutes.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.